-
Looks bad.
As the article says, there are mechanisms for production and purchase elsewhere in this situation. If the drug is as valuable as the action of the US govt. seems to indicate it is, Gilead will need to do and will be doing deals with other production outfits elsewhere to meet demand.
And if there is no demand...meh.
Howard-
Looks bad - and is a transparent attempt at damage limitation and to swing opinion that the administration is doing all it can.
But a recent Forbes article on the company's pricing decision for the drug suggests it is not as effective as has been touted. So have they just bought up 90% of the world's snake oil production?
I don't know enough about the treatment to have formed an opinion either way - this was not my area when I worked in pharma.
c00ps
Disgraceful behaviour:
https://www.theguardian.com/us-news/2020/jun/30/us-buys-up-world-stock-of-key-covid-19-drug